Where do King Pharmaceuticals's ratios come from?

Every ratio is computed from King Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

King Pharmaceuticals KG Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Leverage
Debt-to-equity	1.5×+0.1×	1.4×+0.1×	1.2×+0.1×	1.2×—	——
Debt-to-assets	0.2×0.0×	0.2×0.0×	0.2×0.0×	0.2×—	——
Per Share
Book value per share	$15.66-30.0%	$22.38+20.5%	$18.57-42.6%	$32.38+2,006%	$1.54-8.2%
Valuation
Market capitalization	$70.42M-67.6%	$79.28M-62.5%	$211.43M-15.0%	$248.69M—	——
Enterprise value	$184.93M-50.0%	$231.11M-33.4%	$347.1M-11.2%	$390.96M—	——
Price / sales	1.6×-24.3×	2.3×-6.1×	8.4×-21.3×	29.7×—	——
Price / book	0.7×-1.0×	0.6×-0.9×	1.5×-0.2×	1.7×—	——
EV / sales	4.5×-41.9×	6.8×-7.1×	13.9×-32.9×	46.7×—	——

Ask your AI about King Pharmaceuticals.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do King Pharmaceuticals's ratios come from?: Every ratio is computed from King Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.